Revenue
$6.9M
▼ 23.2% YoY
Net Income
-$212.4M
▲ 27.5% YoY
EPS
$-2.43
▲ 51.4% YoY
Cash
$653.5M
▲ 355.9% YoY
FY 2025 · As of 2025-12-31
Last 90 days
| Insider | Type | Date | Shares | Price | Value | |
|---|---|---|---|---|---|---|
BIENAIME JEAN JACQUES | Sell | Jun 5, 2026 | 500 | $19.44 | $10K | Form 4 ↗ |
BIENAIME JEAN JACQUES | Sell | Jun 5, 2026 | 10.0K | $19.41 | $194K | Form 4 ↗ |
BIENAIME JEAN JACQUES | Buy | Jun 5, 2026 | 6.0K | $19.48 | $117K | Form 4 ↗ |
BIENAIME JEAN JACQUES | Buy | Jun 5, 2026 | 3.5K | $19.46 | $68K | Form 4 ↗ |
BIENAIME JEAN JACQUES | Buy | Jun 5, 2026 | 1.0K | $19.27 | $19K | Form 4 ↗ |
BIENAIME JEAN JACQUES | Buy | May 15, 2026 | 5.0K | $20.70 | $104K | Form 4 ↗ |
Higgins Jack Chief Scientific Officer | Sell | Apr 2, 2026 | 9.4K | $21.64 | $204K | Form 4 ↗ |
Rosett Max Chief Financial Officer | Vest | Apr 2, 2026 | 31.8K | $1.05 | $33K | Form 4 ↗ |
Rosett Max Chief Financial Officer | Vest | Apr 2, 2026 | 39.7K | $1.35 | $54K | Form 4 ↗ |
Rosett Max Chief Financial Officer | Sell | Apr 2, 2026 | 63.7K | $21.91 | $1.39M | Form 4 ↗ |
Rosett Max Chief Financial Officer | Sell | Apr 2, 2026 | 1.3K | $22.48 | $30K | Form 4 ↗ |
Higgins Jack Chief Scientific Officer | Gift | Mar 30, 2026 | 6.3K | $0.00 | $0 | Form 4 ↗ |
SIEGALL CLAY B President and CEO | Buy | Mar 27, 2026 | 25.4K | $19.67 | $501K | Form 4 ↗ |